Statistics for Avadel Pharmaceuticals PLC (id:6508 AVDL)
Valuation metrics
Market cap
994.45M
Enterprise value
946.66M
Trailing P/E (ttm)
-5.16
Forward P/E
15.18
PEG ratio
15.18
Price/Sales (ttm)
7.20
Price/Book (mrq)
13.32
Enterprise Value/Revenue
6.85
Enterprise Value/EBITDA
-15.27
Overview
Shares outstanding
96.36M
Float
83.31M
Shares short
9.79M
% Held by insiders
5.00%
% Held by institutions
3.00%
Average volume (10 days)
1.01M
Average volume (90 days)
Price summary
52-Week low
9.41
52-Week high
19.09
52-Week change
-35.79%
Beta
50-Day moving average
12.29
200-Day moving average
14.84
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
-52.53%
Operating margin
3.00%
Operational effectiveness
Return on assets
-22.14%
Return on equity
-78.54%
Income statement
Revenue (ttm)
1.48
Revenue per share (ttm)
1.48
Quarterly revenue growth (yoy)
6.13
Gross profit (ttm)
27.12M
EBITDA
-62,007,000.00
Net income to common (ttm)
-72,575,000.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
613.22%
Balance sheet
Total cash (mrq)
65.81M
Total cash per share (mrq)
3.00
Total debt (mrq)
38.25M
Total Debt/Equity (mrq)
51.24
Current ratio (mrq)
297.40%
Book value per share (mrq)
3.00
Cash flow
Cash flow statement
-82,809,000.00
Levered free cash flow (LFCF)
-58,922,500.00